Qube Research & Technologies Ltd - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 127 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q4 2022$1,249,280
+185.9%
84,525
+144.3%
0.01%
+133.3%
Q2 2022$437,000
-64.2%
34,598
-46.5%
0.00%
-70.0%
Q1 2022$1,222,000
+222.4%
64,612
+382.1%
0.01%
+66.7%
Q1 2021$379,000
+9.5%
13,402
-30.9%
0.01%
-97.4%
Q3 2019$346,000
-21.4%
19,395
-3.0%
0.23%
+119.0%
Q2 2019$440,00020,0000.10%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Karst Peak Capital Ltd 1,349,185$43,430,00078.86%
AIA Investment Management Private Ltd 354,035$11,396,0002.43%
Bellevue Group AG 400,029$12,877,0000.82%
Prince Street Capital Management LLC 81,400$2,620,0000.55%
PRUDENTIAL PLC 4,247,748$136,735,0000.44%
OppenheimerFunds, Inc. 2,936,797$94,536,0000.11%
SECTORAL ASSET MANAGEMENT INC 31,628$1,018,0000.11%
Tibra Equities Europe Ltd 27,900$898,0000.11%
Jabre Capital Partners S.A. 10,000$322,0000.11%
SCHRODER INVESTMENT MANAGEMENT GROUP 1,803,955$58,069,0000.10%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders